China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 January 2014, Volume 24 Issue 1 Previous Issue Next Issue

Expression and clinical significance of PAK5 protein expression in osteosarcoma

TIAN Cong,TANG Li-na,LIN Feng,SHEN Zan,CHEN Jie,YAO Yang,MIN Da-liu

2014, 24 (1): 1-7. doi: 10.3969/j.issn.1007-3969.2014.01.001

Abstract ( 262) PDF (2014KB) ( 894 )

The expression of ABCC4/MRP4 and ABCC5/MRP5 gene in the NK/T cell lymphoma and its relationship with clinical efficacy

LIRu-ping,HANLi-juan,ZHANGXu-dong,ZHANGMing-zhi,HUTeng-teng,QINBei-bei,WENJian-guo

2014, 24 (1): 8-14. doi: 10.3969/j.issn.1007-3969.2014.01.002

Abstract ( 287) PDF (1881KB) ( 977 )

The heterogenous expression and significance of multidrug resistance-associated proteins in primary tumors and metastatic lymph nodes in patients with esophageal squamous cell carcinoma

FANG Qiang,DONG Dan-dan,YANG Hong,REN Guang-guo,HAN Yong-tao,XIAO Bo

2014, 24 (1): 15-20. doi: 10.3969/j.issn.1007-3969.2014.1.003

Abstract ( 222) PDF (2109KB) ( 941 )

Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women

ZHONG Fang-fang,ZHANG Wei,WANG Cheng-hui,LI Xin-xia,SHUI Ruo-hong,YANG Wen-tao,DU Xiang

2014, 24 (1): 21-28. doi: 10.3969/j.issn.1007-3969.2014.01.004

Abstract ( 208) PDF (3646KB) ( 1257 )

The radiosensitizing effects of cryptotanshinone on H22 hepatoma-bearing mice

YE Yin-tao,WANG Chen,SONG Xiao-kun,ZHANG Jie,GAO Ning

2014, 24 (1): 29-34. doi: 10.3969/j.issn.1007-3969.2014.01.005

Abstract ( 278) PDF (1352KB) ( 1172 )

The effects and mechanisms of Gankyrin silencing on reversing the cisplatin resistance of human ovarian cancer SKOV3/DDP cell line

WANG Qian,CHENG Kun

2014, 24 (1): 35-40. doi: 10.3969/j.issn.1007-3969.2014.01.006

Abstract ( 342) PDF (2092KB) ( 1121 )

Expression of serum TK1 in human breast tumor and its clinical significance

REN Ruo-bing,XU Cheng,LI Ya-fen,JIN Ye-ning,HE Jian-rong

2014, 24 (1): 41-45. doi: 10.3969/j.issn.1007-3969.2014.01.007

Abstract ( 438) PDF (1022KB) ( 1172 )

S-1 plus oxaliplatin for the treatment of advanced small bowel adenocarcinoma

ZHANG Hui-qing, HE Bo, LU Shan, WANG Yan-hua, SONG Rong-feng, WAN Yi-ye

2014, 24 (1): 46-51. doi: 10.3969/j.issn.1007-3969.2014.01.008

Abstract ( 392) PDF (1085KB) ( 1170 )

Establishment of daily quality assurance program and analysis of dosimetric characteristics’ longterm stability for mobile intraoperative radiation therapy accelerator

WANG Jun-qi,MA Jin-li,HU Wei-gang,SUN Li-ning

2014, 24 (1): 52-56. doi: 10.3969/j.issn.1007-3969.2014.01.009

Abstract ( 387) PDF (1267KB) ( 1064 )

Prediction of peripheral blood lymphocytes radiosensitivity in normal tissue radiation damage in oncology patients with radiotherapy

NIU Xiao-shuang, LIU Yong, KONG Lin

2014, 24 (1): 57-61. doi: 10.3969/j.issn.1007-3969.2014.01.010

Abstract ( 219) PDF (966KB) ( 891 )

Association between microRNA expression and chemotherapy in colorectal cancer

YU Qi-he,ZHANG Wen

2014, 24 (1): 62-68. doi: 10.3969/j.issn.1007-3969.2014.01.011

Abstract ( 263) PDF (1035KB) ( 862 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat